Levobupivacaine Thermogel for Long-acting Analgesia
Ellison Neves de Lima1, Ana Rosa Brissant de Andrade1, Leila Bastos Leal2,3
1Center of Cosmetic and Pharmaceutical Development, NUDFAC, Department of Pharmaceutical Sciences, Federal University of Pernambuco, UFPE, Recife, PE, Brazil.
Abstract:
The adequate management of analgesia, by pharmacological methods or not, is a great challenge. Local anesthetics are used for pain relief, mainly by parenteral, intramuscular, catheter, and other routes of administration. The use of in situ forming systems becomes an alternative for the control of pain. The present research investigates development of thermogels containing poloxamer and levobupivacaine. All formulations were prepared by the cold method; the compatibilities of the excipients were evaluated by DSC, rheology and viscosities, transition temperature, syringeability, release kinetics, and permeation. The compatibility of the tested excipients with the drug was initially observed; all formulations had a viscosity increase at 37°C. Different delivery rates were observed in both the release and permeation studies. The developed systems maintained the in vitro release of the drug for a long period, likely decreasing side effects in vivo and avoiding the need for supplementary analgesia by other routes.
More Related Videos
07:17Measurement of Dynamic Force Acted on Water Strider Leg Jumping Upward by the PVDF Film Sensor
Published on: August 3, 2018
12:40A Modified Murine Heterotopic Heart Transplant Protocol Matching Contemporary Standards of Aseptic Technique, Anesthesia, and Analgesia
Published on: September 28, 2022
Related Concept Videos
Analgesia and Pain Management
Forces Acting on Chromosomes
Microtubules and motor proteins exert two types of forces on...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Drugs Acting on Autonomic Ganglia: Blockers
Direct-Acting Cholinergic Agonists: Therapeutic Uses
